Page last updated: 2024-08-25

cholest-5-ene-3,4-diol and Immunologic Deficiency Syndromes

cholest-5-ene-3,4-diol has been researched along with Immunologic Deficiency Syndromes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bergman, P; Björkhem-Bergman, L; Diczfalusy, U; Ekström, L; Eliasson, E; Lindh, JD; Norlin, AC; Nylén, H	1

Trials

1 trial(s) available for cholest-5-ene-3,4-diol and Immunologic Deficiency Syndromes

Article	Year
Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study. Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4 Topics: Adolescent; Adult; Aged; Biomarkers, Pharmacological; C-Reactive Protein; Female; Genotype; Humans; Hydroxycholesterols; Immunologic Deficiency Syndromes; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Respiratory Tract Infections; Vitamin D	2013

Article

Year

Serum levels of 25-hydroxyvitamin D and the CYP3A biomarker 4β-hydroxycholesterol in a high-dose vitamin D supplementation study.

Drug metabolism and disposition: the biological fate of chemicals, 2013, Volume: 41, Issue:4

Topics: Adolescent; Adult; Aged; Biomarkers, Pharmacological; C-Reactive Protein; Female; Genotype; Humans; Hydroxycholesterols; Immunologic Deficiency Syndromes; Male; Middle Aged; Polymorphism, Single Nucleotide; Receptors, Calcitriol; Respiratory Tract Infections; Vitamin D

2013